Jubilant Ingrevia Surges Ahead with Impressive Q2 Earnings
Jubilant Ingrevia Ltd reported a 17.74% rise in consolidated net profit, reaching Rs 69.47 crore for Q2 ending September 2025, from Rs 59 crore last year. Revenue increased to Rs 1,120.73 crore. The company credits growth to its specialty chemicals and nutrition businesses, maintaining profitability despite market challenges.
- Country:
- India
In a robust showing for the second quarter of the fiscal year ending September 30, 2025, Jubilant Ingrevia Ltd, a leader in specialty chemicals, reported a significant 17.74% rise in consolidated net profit to Rs 69.47 crore. This marks an increase from Rs 59 crore in the same quarter of the previous year, as per the latest regulatory filing.
The company's total revenue from operations during the quarter saw an upswing, reaching Rs 1,120.73 crore compared to Rs 1,045.24 crore recorded during the same period last year. Total expenses were higher at Rs 1,038.6 crore, up from the previous year's Rs 975.34 crore.
Company Chairman Shyam S. Bhartia and Co-Chairman Hari S. Bhartia attributed the solid performance to a double-digit year-on-year growth in the specialty chemicals segment. They further expressed optimism for continued growth, citing developments in their nutrition and anticipated recovery in the Acetyls portfolio.
Google News